Back
BioXcel Therapeutics Quote, Financials, Valuation and Earnings
NOW is the time to get in on this trillion-dollar megatrend
Get it here.
Sell
20
BTAI
BioXcel Therapeutics
Last Price:
2.54
Seasonality Move:
13.65%
7 Day Trial
ALL ACCESS PASS
$
7
The little-known AI stock you need to read about now...
Get the name - FREE.BioXcel Therapeutics Price Quote
$2.54
-0.07 (-2.68%)
(Updated: April 26, 2024 at 1:50 PM ET)
BioXcel Therapeutics Key Stats
Sell
20
BioXcel Therapeutics (BTAI)
is a Sell
Day range:
$2.55 - $2.72
52-week range:
$1.91 - $29.56
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
55.09
P/B ratio:
0%
Volume:
659.1K
Avg. volume:
513.7K
1-year change:
-87.57%
Market cap:
$79.8M
Revenue:
$1.4M
EPS:
$-6.14
How Much Does BioXcel Therapeutics Make?
-
How Much Are BioXcel Therapeutics's Sales Annually?
BTAI Revenues are $1.4M -
How Much Profit Does BioXcel Therapeutics's Make A Year?
BTAI net income is -$179.1M
Is BioXcel Therapeutics Growing As A Company?
-
What Is BioXcel Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.58% -
What Is BioXcel Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
BioXcel Therapeutics Stock Price Performance
-
Did BioXcel Therapeutics Stock Go Up Last Month?
BioXcel Therapeutics share price went down by -8.42% last month -
Did BTAI's Share Price Rise Over The Last Year?
BTAI share price fell by -87.57% over the past 1 year
What Is BioXcel Therapeutics 52-Week High & Low?
-
What Is BioXcel Therapeutics’s 52-Week High Share Price?
BioXcel Therapeutics has traded as high as $29.56 over the past 52 weeks -
What Is BioXcel Therapeutics’s 52-Week Low Share Price?
BioXcel Therapeutics has traded as low as $1.91 over the past 52 weeks
BioXcel Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy BioXcel Therapeutics?
-
How Much Debt Does BioXcel Therapeutics Have?
Total long term debt quarterly is $100.6M -
How Much Cash Does BioXcel Therapeutics Have?
Cash and short term investments quarterly total is $65.2M -
What Is BioXcel Therapeutics’s Book Value Per Share?
Book value per share is -1.89
Is BioXcel Therapeutics Cash Flow Positive?
-
What Is BTAI Cash Flow From Operations?
Cash flow from operations (TTM) is -$155M -
What Is BioXcel Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $26.5M -
What Is BioXcel Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$20K
BioXcel Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
BTAI return on invested capital is -171.12% -
What Is BioXcel Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -127.86% -
What Is BTAI Return On Equity?
ROE is a measure of profitability and is -2323.67%
BioXcel Therapeutics Earnings Date & Stock Price
-
What Is BioXcel Therapeutics's Stock Price Today?
A single share of BTAI can be purchased today for 2.61 -
What Is BioXcel Therapeutics’s Stock Symbol?
BioXcel Therapeutics trades on the nasdaq under the ticker symbol: BTAI -
When Is BioXcel Therapeutics’s Next Earnings Date?
The next quarterly earnings date for BioXcel Therapeutics is scheduled on May 8, 2024 -
When Is BTAI's next ex-dividend date?
BioXcel Therapeutics's next ex-dividend date is April 26, 2024 -
How To Buy BioXcel Therapeutics Stock?
You can buy BioXcel Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
BioXcel Therapeutics Competitors
-
Who Are BioXcel Therapeutics's Competitors?
Below is a list of companies who compete with BioXcel Therapeutics or are related in some way:
BioXcel Therapeutics Dividend Yield
Data Unavailable
BioXcel Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 4.4% |
| Revenue: | 57.98% | -49.28% |
Analyst Recommendations
| Buy Recommendations: | 2 |
|---|---|
| Hold Recommendations: | 3 |
| Sell Recommendations: | 0 |
| Price Target: | 7.25 |
| Upside from Last Price: | 177.78% |